Please assess the completion status of the following clinical trial:

Trial Title: A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Between the ages of 13 and 21~* Self-reported symptoms of depression~* Will be residing in the USA for the duration of the 5-week study~* Under the care of a US-based primary care and/or licensed mental healthcare provider and willing and able to provide the name and contact information of the provider during consent appointment.~* English fluency and literacy of adolescent and consenting legal guardian if under 18~* Access to a smartphone (iPhone 5s or later or running Android 4.4 KitKat or later) and regular internet access~* Willing to provide informed e-consent/assent and have legal guardian willing to provide informed e-consent if under 18.~Exclusion Criteria:~* Self-reported lifetime suicide attempt or active self-harm or active suicidal ideation with intent~* Have a diagnosis by a clinician of bipolar disorder, substance use disorder, or any psychotic disorder including schizophrenia~* Incapable of understanding or completing study procedures and digital intervention as determined by participant, patient/legal guardian, healthcare provider, or clinical research team

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 21 Years
- Healthy Volunteers: t

Study Arms:
- Limbix Spark (Type: EXPERIMENTAL): A 5 week CBT-based intervention
- Psychoeducation (Type: ACTIVE_COMPARATOR): 5 weeks of psychoeducation about depression. Upon completion, participants will be automatically enrolled into the Limbix Spark CBT-based intervention

Based on this trial design, predict the completion outcome and termination type (if applicable).